Year: 2020

– Le recrutement de patients dans les études de phase 1/2 sur l’antagoniste EOS-850 A2AR et l’anticorps anti-TIGIT avec FCγR activé EOS-448 se poursuit avec des données initiales attendues pour le premier semestre 2021 – – La solide position de trésorerie de l’entreprise soutiendra les opérations et le développement clinique en cours jusqu’en 2023 –CAMBRIDGE, Massachusetts et GOSSELIES, Belgique, 12 nov. 2020 (GLOBE NEWSWIRE) — iTeos Therapeutics, Inc. (Nasdaq : ITOS), une société biopharmaceutique au stade clinique pionnière dans la découverte et le développement d’une nouvelle génération de traitements d’immuno-oncologie hautement différenciés pour les patients, a annoncé aujourd’hui ses résultats financiers pour le troisième trimestre clos au 30 septembre 2020...

– Patientenaufnahme in Phase-I/II-Studien zum EOS-850 A2AR-Antagonisten und zum EOS-448 FCγR-gebundenen Anti-TIGIT-Antikörper wird fortgesetzt; erste Daten werden im ersten Halbjahr 2021 erwartet – – Starke Barmittelposition zur Unterstützung der laufenden klinischen Entwicklung und der Geschäftstätigkeit bis 2023 –CAMBRIDGE, Mass. und GOSSELIES, Belgien, Nov. 12, 2020 (GLOBE NEWSWIRE) — iTeos Therapeutics, Inc. (Nasdaq: ITOS), ein biopharmazeutisches Unternehmen im Bereich der klinischen Forschung, das Vorreiter bei der Entdeckung und Entwicklung einer neuen Generation hochdifferenzierter immunonkologischer Therapeutika für Patienten ist, gab heute die Geschäftsergebnisse für das dritte Quartal zum 30. September 2020 sowie die jüngsten geschäftlichen Höhepunkte bekannt.„Wir konzentrieren uns darauf, unsere...

Health spending in Canada was approximately $264 billion in 2019, 30% represents private-sector spending1One of the main pain points for employers and insurers is the multiple vendors required to cover the spectrum of healthcare servicesCloudMD delivers one centralized platform that addresses access to primary and specialist care, mental health support, and educational resourcesThe solution provides personalized care plans unique to each individual through proven systems, triage, assessment and navigationCreates an improved healthcare experience resulting in better outcomes, faster adoption rates and increased engagementLed by Karen Adams, Global Head, Enterprise Health Solutions, an industry leader with over 20 years’ experience in enterprise health and wellnessVANCOUVER, British Columbia, Nov. 12, 2020 (GLOBE NEWSWIRE) — CloudMD...

TORONTO, Nov. 12, 2020 (GLOBE NEWSWIRE) — Emerita Resources Corp. (TSX-V: EMO) (the “Company” or “Emerita”) is pleased to announce that important progress has been made towards the resolution of the ongoing Aznalcóllar legal proceedings in Spain which appears to be entering the final stages after more than five years. The Superior Court judges responsible for the case have concluded that further investigations are not required as they now have sufficient evidence to establish that crimes were committed in the awarding of the Aznalcóllar public tender to Minorbis-Grupo Mexico (“Minorbis”). There have been two appeals heard in the case already and these have been systematically denied by the Superior Court which has been consistent in its rulings throughout the process; that is they have ruled consistently that there is the existence...

Early access program launched for the next generation of the ARESupa Universal Pathogenome Assay based on targeted next-generation sequencing (NGS) of native specimensFirst commercial orders completed, assay design based on proprietary ARESdb to comprehensively cover antibiotic resistance markersReceived bulk order from public health agencyGAITHERSBURG, Md. and VIENNA, Austria, Nov. 12, 2020 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq: OPGN, “OpGen”), announced today that its group company and wholly owned subsidiary Ares Genetics GmbH (Vienna, Austria; “Ares Genetics”) launched an early access program for its novel, NGS-based molecular antibiotic resistance (AMR) test for comprehensive profiling of genetic AMR markers from native specimen by a hybrid-capture based targeted NGS assay.Information on genetic antibiotic resistance of pathogens...

TORONTO, Nov. 12, 2020 (GLOBE NEWSWIRE) — Revival Gold Inc. (TSXV: RVG, OTCQB: RVLGF) (“Revival Gold” or the “Company”), a growth‐focused gold exploration and development company, announces results from an additional five drill holes along with partial results from a sixth drill hole from the Company’s 2020 drilling program on the past-producing Beartrack-Arnett Gold Project (“Beartrack-Arnett”) located in Idaho, USA.Five of the six holes released today are infill core holes drilled in the Haidee target area at Beartrack-Arnett. The holes were drilled to confirm projections of resource blocks from the 2020 Mineral Resource estimate (see Technical Report on the Beartrack-Arnett Gold Project, Lemhi County, Idaho, USA dated February 21st, 2020) and to upgrade resources from the Inferred category to the Indicated category. All five...

Palm Beach, Florida, Nov. 12, 2020 (GLOBE NEWSWIRE) — PMV Consumer Acquisition Corp. (NYSE: PMVC.U) (the “Company”) today announced that, commencing on November 12, 2020, holders of the units (the “Units”) sold in the Company’s initial public offering may elect to separately trade shares of the Company’s Class A common stock (the “Common Stock”) and warrants (the “Warrants”) included in the units.The Common Stock and Warrants received from the separated Units will trade on the New York Stock Exchange (“NYSE”) under the symbols “PMVC” and “PMVC WS”, respectively. Units that are not separated will continue to trade on the NYSE under the “PMVC.U” ticker symbol. No fractional Warrants will be issued upon separation of the Units and only whole Warrants will trade. Holders of Units will need to have their brokers contact Continental...

WILMINGTON, N.C., Nov. 12, 2020 (GLOBE NEWSWIRE) — nCino, Inc. (NASDAQ: NCNO) will report financial results for its third quarter which ended October 31, 2020 after the market close on Wednesday, December 9, 2020. nCino will host a conference call and webcast that day at 4:30 p.m. ET to discuss its financial results.What: nCino’s Third Quarter Fiscal Year 2021 Financial Results Conference CallWhen: Wednesday, December 9, 2020 at 4:30 p.m. ETWebcast Link: https://investor.ncino.com/ Replay: A webcast replay will be available on the Investor Relations section of nCino’s website following the call. About nCinonCino (NASDAQ: NCNO) is the worldwide leader in cloud banking. The nCino Bank Operating System® empowers financial institutions with scalable technology to help them achieve revenue growth, greater efficiency, cost savings and...

MONTRÉAL, 12 nov. 2020 (GLOBE NEWSWIRE) — (TSX-V: VSR) Ressources Minières Vanstar Inc. (ou «La Société» ou «Vanstar») annonce l’acquisition de 31 titres miniers d’Osisko Metals Inc. afin d’agrandir la propriété Felix détenue à 100%, de plus de 99%, situé sur la formation du Groupe Chicobi, ceinture aurifère de l’Abitibi (Québec, Canada).Les titres miniers acquis sont situés directement au sud-ouest et contigus à l’actuelle propriété Felix. La nouvelle propriété fusionnée comprendra 69 titres miniers et couvrira environ 3 259,6 ha. « Cette transaction reflète l’esprit de notre équipe de gestion proactive qui se concentre sur la croissance de Vanstar et nous sommes très heureux d’étendre notre empreinte dans le Chicobi, une zone active d’exploration et de nouvelles découvertes aurifères...

FREEMONT, Calif., Nov. 12, 2020 (GLOBE NEWSWIRE) — Aehr Test Systems (NASDAQ: AEHR), a worldwide supplier of semiconductor test and reliability qualification equipment, today announced that it will participate at the Craig-Hallum 11th Annual Alpha Select Virtual Conference on Tuesday, November 17, 2020. Aehr Test President and CEO Gayn Erickson and CFO Ken Spink will be hosting virtual meetings with investors throughout the day.“We look forward to discussing our semiconductor wafer level and singulated die test and burn-in solutions and the markets they serve with investors,” said Mr. Erickson. “Aehr Test provides complete production solutions for improving yield and reliability of semiconductors, and devices such as silicon carbide semiconductors used in electric and hybrid electric vehicles, silicon photonics devices used in data...